SEOUL, South Korea — (BUSINESS WIRE) — ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for a Phase 1 clinical trial and that it is now ready to initiate a p…
ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial
SEOUL, South Korea — (BUSINESS WIRE) — ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for a Phase 1 clinical trial and that it is now ready to initiate a p…